Asthma and COPD Drug Market Analysis - Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC231

Owing to the rising patient population, the current asthma and COPD market is growing at a fast pace. Factors such as patent expiry of major drug brands and price erosion will further propel the growth of this market. It has been further analyzed that the global asthma and COPD drug market is expected to grow at a moderate CAGR. Presently, the asthma drug segment commanded the overall asthma and COPD market.
 
In the medical practice, asthma is defined as a condition in which there is an inflammation and constriction of airways through which a body breathes owing to the various environmental triggers. It has been regarded as a serious medical disorder and it has been estimated that around 300 million people globally are suffering from asthma. The drug therapy is most commonly used for the treatment of asthma and for the prevention of this disorder patients are advised to avoid any type of triggers. Over the past decades, pharmaceutical companies have innovated effective asthma drugs that act faster and efficiently treat asthma. The newest generation of asthma curing drugs such as AstraZeneca's Symbicort, and GlaxoSmithKline's Advair are estimated to command a major gain over the older products available in the market. 
 
However, AstraZeneca, GlaxoSmithKline, and Merck are expected to be the market leaders until their drug patents expire in the future years. Drugs such as Singulair, Symbicort, and Advair are estimated to command the highest share in the asthma and COPD market during the forecast period. Presently, Advair was observed to be the market leader to treat asthma followed by Singulair which was the second largest revenue generating drug in terms of revenue. 
 
Also, owing to the high demand of new drug entrants in combinational therapies, inhaled corticosteroids and beta-agonists, there is an intense competition in the asthma market. There are numerous growing opportunities in the asthma and COPD market as majority of large companies are concentrating on contract manufacturing outsourcing (CMO). Also, the key market players are engaged in the development of new products that provide better treatment for asthma.
 
This research report is designed to analyze and estimate the performance, market demand, and size of the global asthma and COPD market across the world. This report includes historical data and forecasts and market size, value chain, product sales, their forecasts, pipeline products and various other key factors that are boosting or impeding the growth of this market. The major factors driving this market is rising awareness about the diagnosis for Asthma and COPD, and availability of affordable healthcare equipment for the determination of illness in the rural areas. These factors are set to propel the growth of this market and provide immense growth opportunities for companies across the globe. There has been a significant rise in the number of patients suffering with asthma in China over the current years. Factors such as rapid urbanization, air pollution, rising smoking activities, and lifestyle change are bolstering this growth. In the urban China towns, there is a higher occurrence of asthma symptoms as compared to the rural areas.
 
Owing to the high demand of new drug entrants in combinational therapies, inhaled corticosteroids and beta-agonists, there is an intense competition in the asthma market. Also, the key market players are engaged in the development of new products that provide better treatment for asthma. The players in the asthma and COPD drug market are Novartis AG, GlaxoSmithKline (GSK), Merck & Co., Boehringer Ingelheim, Abbott Laboratories, AstraZeneca, Teva Pharmaceutical Industries, Roche Holding AG, Vectura Group, and Pfizer. Other players in the value chain include Aerovance Inc., Mylan, Alkermes Inc., Genentech Inc., Almirall SA, Sepracor, Inc., and Skyepharma plc.
 


Related Reports

Ambulatory Surgical and Emergency Centers Market By Service Type (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory surgical and emergency centers market is expected to grow at a CAGR of 6.2% over the forecast period 2019 to 2026 and market size is poised to reach US$ 203.1 Bn by 2026. Ambulatory surgery and emergency centers are medical care facilities that provide same-day surgery care which also includes consultation and diagnosis. It is a more convenient alternative to hospital based outpatient pro

Ambulatory Health Care Services Market By Type (Primary Care Offices, Medical Specialty, Emergency Departments, Surgical Specialty), By Application (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory health care services market size is expected to surpass US$ 4.4 Tn by 2026 and will grow at a noteworthy CAGR of 5.9% over the forecast period 2019 to 2026. Ambulatory service centers (ASC) also referred as outpatient care centers. These are medical care facilities that provide outpatient services such as consultation, diagnosis, treatment, and intervention services. It is a more convenie

Ambulatory EHR Market By Application (Patient Management, Practice Management, E-prescribing, Population Health Management, Referral Management, Health Analytics, Decision Support), By Delivery Mode (Client Server-based, Web-based), By End User Mode (Independent Ambulatory Centers, Hospital-owned Ambulatory Centers) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory EHR market size is expected to reach US$ 6.8 billion by 2026 and will grow at a CAGR of around 6.0% over the forecast period 2019 to 2026. The digital version of the patient’s record is known as the electronic health records. It includes a wide range of patient’s information such as medical history, ongoing medication, allergies, personal statistics, the status of immunization, demographics, and laborator

Cancer Biomarkers Market By Type (Protein, Genetic, Others), By Technology (Omics Technology, Immunoassay, Imaging Technology, Cytogenetic Testing), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Leukemia, Thyroid gland Cancer, Kidney Cancer, Bladder Cancer, Others), By Application (Diagnosis, Prognosis, Research, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global cancer biomarkers market size is expected to reach around US$ 29.8 Bn by 2026 and will grow at noteworthy CAGR of around 11.9% over the forecast period 2019 to 2026. Cancer biomarker is a substance that helps to indicate the presence of cancer in the body. This substance may be a molecule secreted by a tumor or specific response of the body to a tumor. Genetic, proteomic

4D Printing in Healthcare Market By Component(Equipment, Software & Services, Programmable Materials), By Technology (PolyJet, FDM, Stereolithography, SLS), By Application (Patient Specific Implant, Medical Research Models, Surgical Guides), By End User (Hospitals, Dental Laboratories, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global 4D printing in healthcare market size is expected to reach around US$ 34.1 Mn by 2026 growing at a CAGR of around 29.6% over the forecast period 2019 to 2026. 4D printing is the latest technology in healthcare that is going to revolutionize the artificial organs and prosthetics industry. 4D printing is a product of collaboration work between MIT’s Lab and Stratasys. 4D printing is evolved 3D p

Healthcare Consulting Services Market By Type of Service (IT Consulting, Digital consulting, Financial Consulting, Operation Consulting, Strategy Consulting, HR & Talent Consulting), By End User (Life Science Companies, Hospitals, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare consulting services market size is expected to reach around US$ 22.8 Bn by 2026 and growing at a CAGR of around 9.8% over the forecast period 2019 to 2026. Healthcare consultancy service providers advice life science companies, government bodies, hospitals, insurance companies, and research institutes about business strategies. Digital consulting, financial consulting, operations consulta

Cart Summary